Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Latest "Biomarker discovery Driving technologies" News Stories

01:22 EDT 31st July 2014 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 7,300+

Relevant

Bioanalytical CRO offers validation of proinflammatory, cytokine multiplex biomarker assays

In an industry first, bioanalytical CRO Tandem Labs has announced the availability of biomarker assays for human clinical studies using the Meso Scale Discovery V-PLEX biomarker platform, which have been already validated by Tandem in human serum. 

KineMed sets IPO range

Biomarker discovery company KineMed Inc. (Emeryville, Calif.) amended its IPO on NASDAQ and now plans to sell 4.5 million shares at $6.50-$7.50. At the $7 midpoint, the company would raise $31.5 million and be valued at $113.8 million. Feltl and Co.;...

Biomarker discovery may lead to new HIV treatment

(WHITECOAT STRATEGIES, LLC) Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine...

Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling

Cypher Genomics And Illumina, Inc. Enter Agreement To Facilitate Genomic Biomarker Discovery

KineMed pulls IPO

Biomarker discovery company KineMed Inc. (Emeryville, Calif.) withdrew its IPO on NASDAQ, citing "market conditions." The company declined to comment on future financing plans. Last month, KineMed amended its IPO to sell 4.5 million shares at $6.50-$...

07.28.14 -- Scientists Report Discovery Of Biomarker For HIV Vaccine; Teva Acquires Labrys

07/28/14 Bioresearch Online Newsletter

First biomarker discovered for depression in teenage boys

According to a survey from the National Institute of Mental Health, approximately 11.2% of teens in the US aged between 13 and 18 years have suffered from severe depression at some point in their lives. Now, researchers from the UK have discovered th...

Biomarker Scout

Alessandra Cervino has joined Paris-based metagenomics specialist Enterome Bioscience SA as Head of Discovery.

PPD Appoints Biomarker Lab Director

Bennett brings 25 years of lab and biomarker experience

WuXi PharmaTech, PBI In Biomarker Alliance

Gains access to PBI’s biomarker assays to support clinical testing services

Merck Data Could Support Use Of PD-L1 Biomarker In Lung Cancer

Data suggest the biomarker could be useful in lung cancer to help identify the 25% of patients who benefit the most, according to data presented at the American Association for Cancer Research meeting. But the biomarker looks less useful in melanoma.

Cypher Genomics Announces the Appointment of Adam Simpson as President and COO

The company provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting.

New Biomarker for Esophageal Cancer

Findings from University Hospitals Case Medical Center and Case Western Reserve University School of Medicine at Digestive Disease Week 2014 A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its pr...

WuXi PharmaTech Forms Biomarker Partnership with Targos

WuXi PharmaTech formed a clinical biomarker partnership with Targos GmbH, a German company that specializes in biomarker services. The partnership will focus on validation of biomarkers in cancer. Targos will provide know-how, services and standards...

Do people with autism struggle with driving?

In the first pilot study asking adults on the autism spectrum about their experiences with driving, researchers at Drexel University found significant differences in self-reported driving behaviors and perceptions of driving ability in comparison to...

Health Tip: Avoid Driving During Flood Warning

-- If the National Weather Service in your area has issued a flood warning, experts say you should avoid driving unless absolutely necessary. The Ready.gov website offers this advice about driving during a flood: Driving in just 6 inches of water...

Tute Genomics biomarker discovery platform to support BYU's Alzheimer's disease genetics research

Tute Genomics announced that its genome annotation and discovery platform will support Brigham Young University's (BYU) efforts to advance Alzheimer's disease genetics research.

Returning to driving after a stroke without being evaluated for ability

Stroke survivors often resume driving without being formally evaluated for ability - though stroke can cause deficits that can impair driving, according to research presented at the American Stroke Association's International Stroke Conference 2014.R...

Parkinson’s Biomarker Initiative Expands Study of Genetics

The Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J.

Driving Innovation through Federal Investments

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving innovation through federal investments. Below are highlights of our written testimony. NIH:  A Driver of the Innovation Pipeline We must continue t...

Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a so...

Driving simulator used to help learn how the visually impaired can drive safely

A diagnosis of hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma often means the end of driving.In about half of the states in the United States and in many other countries, driving with...

Oncology Biomarker Testing: Why the UK Delay?

Amy Butcher investigates why the UK is lagging significantly behind Europe in the uptake of oncology biomarker testing — and looks at what the delays mean for pharma.

Qiagen gains exclusive license for blood disorder biomarker

CeMM Vienna has agreed to allow Qiagen to exclusively license its calreticulin biomarker for undisclosed terms.  -More- 


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks